Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial

Table 7

Laboratory parameters.

Abnormal laboratory investigations/physical examination	Group I	Group II
Urinary protein positive	5	8
Prolonged prothrombin time	1	1
Decreased white blood cell count	1	3
Nausea	4	2
Diarrhea	0	1
Fatigue	2	1
Mild abdominal pain	1	1
Myalgia	3	2

Noticed on days 22 and 30 postinitiation; the decrease was less than 20% in all four cases, and in none of the patients did the count go below 4000 cells/mm [3]. Noticed on day 30 postinitiation of bevacizumab therapy.